Related Experiment Videos
Developing sustainable studies on environmental health.
1Genetic Toxicology Laboratory, University of Vermont, 32 N. Prospect Street, Burlington, VT 05401, USA. ralbertini@zoo.uvm.edu
Mutation Research
|August 17, 2001
Summary
New biomarkers from toxicogenetics and proteomics aid in assessing environmental pollutant effects on human health. Transitional studies are crucial for validating these biomarkers for real-world applications and disease prevention.
Area of Science:
- Environmental toxicology
- Molecular epidemiology
- Biomarker development
Background:
- Emerging fields like toxicogenetics, toxicogenomics, and proteomics offer novel biomarkers.
- Traditional biological responses are also utilized for assessing environmental pollutant impacts.
- Biomarker utility in human health studies requires validation through transitional research.
Purpose of the Study:
- To highlight the role of new molecular biomarkers in environmental health research.
- To emphasize the necessity of transitional studies for biomarker validation.
- To propose integrating molecular epidemiology into toxicological evaluations for human health.
Main Methods:
- Utilizing toxicogenetics, toxicogenomics, and proteomics for biomarker discovery.
- Conducting transitional studies to bridge laboratory findings and field applications.
- Employing prospective or cross-sectional designs for biomarker validation.
Main Results:
- Validated biomarkers are emerging from transitional investigations for sustainable human studies.
- New data support the integration of molecular epidemiology into toxicological assessments.
- Biomarker responses can predict disease likelihood, aiding diagnostics and cancer management.
Conclusions:
- Validated biomarkers enhance the assessment of environmental exposures and susceptibility.
- Integrating molecular data allows for realistic human health assessments and intervention targets.
- Biomarkers can improve disease detection, management, and prevention of environmentally mediated illnesses.